Filtered By:
Condition: Stroke
Management: Medicaid

This page shows you your search results in order of date. This is page number 16.

Order by Relevance | Date

Total 372 results found since Jan 2013.

National trends in utilization of Intravenous thrombolysis and endovascular treatment in acute ischemic stroke (P5.044)
Conclusions:At national level, use of intravenous rt-PA is increasing among all groups proving positive impact of the efforts by organizations and patient education. Given endovascular treatment has now become standard of care; we need to create stroke care models to target this most vulnerable subset of patient population including Hispanics, patients residing in rural areas and insurance status like Medicaid or self-pay status to provide them similar and equal opportunities of treatment as others.Disclosure: Dr. Khatri has nothing to disclose. Dr. Afzal has nothing to disclose. Dr. Qureshi has nothing to disclose. Dr. Qu...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Khatri, R., rauf-afzal, m., Qureshi, M. A., Qureshi, I. A., Maud, A., Rodriguez, G., Cruz-Flores, S. Tags: Neurocritical Care: Ischemic Injury Source Type: research

Disparities in Delivery of Endovascular Therapy: The Florida Puerto Rico Collaboration to Reduce Stroke Disparities Study (CReSD) (S19.003)
Conclusions:There are significant race, regional and hospital disparities in delivery of endovascular care. Efforts should be made to improve access to endovascular treatment to all eligible patients.Disclosure: Dr. Asdaghi has nothing to disclose. Dr. Granzoti Cintra has nothing to disclose. Dr. Wang has nothing to disclose. Dr. Dong has nothing to disclose. Dr. Ciliberti-Vargas has nothing to disclose. Dr. Gutierrez has nothing to disclose. Dr. Koch has nothing to disclose. Dr. Gardener has nothing to disclose. Dr. Marulanda-Londoño has nothing to disclose. Dr. Mueller has nothing to disclose. Dr. Yavagal has rece...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Asdaghi, N., Cintra, L. G., Wang, K., Dong, C., Ciliberti-Vargas, M. A., Gutierrez, C. M., Koch, S., Gardener, H., Marulanda-Londono, E., Mueller, N., Yavagal, D., Mehta, B., Hanel, R., Rose, D. Z., Waddy, S. P., Robichaux, M., Foster, D., Zevallos, J. C. Tags: Best Of: Cerbrovascular Disease and Interventional Neurology Source Type: research

Getting to the Core of Stroke Care: Real Time Chart Review Improves Hospital Compliance with Core Measures (P6.269)
Conclusions:Real time chart review, utilization of a MQA, and alerting of providers is significantly more effective than a process utilizing retrospective chart review based on sampling and manual abstraction in increasing CM compliance. Implementation of these methods reduces CM deficiencies and leads to improved stroke care.Disclosure: Dr. Katsafanas has nothing to disclose. Dr. Furbeyre has nothing to disclose. Dr. Coppen has nothing to disclose. Dr. Hodges has nothing to disclose. Dr. Schnepel has nothing to disclose. Dr. Falk has nothing to disclose. Dr. Alonso has nothing to disclose. Dr. Tran has nothing to disclose...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Katsafanas, C., Furbeyre, J., Coppen, V., Hodges, W., Schnepel, L., Falk, D., Alonso, J., Tran, A., Northcut, M., Toback, A., Silliman, S. Tags: Cerebrovascular Disease Health Services Research Source Type: research

Association between Demographic Characteristics and Hospital Admission in Patients Presenting to the Emergency Department for Transient Neurological Attack (P6.277)
Conclusions:Among patients presenting to the ED with TNA, female sex and race are associated with decreased odds of admission, even after adjusting for socioeconomic and vascular risk factors. Further studies are warranted to determine the public health impact of our results.Disclosure: Dr. Kummer has nothing to disclose. Dr. Parikh has nothing to disclose. Dr. Merkler has nothing to disclose. Dr. Kamel has received personal compensation for activities with Genentech as a speaker. Dr. Kamel has received personal compensation in an editorial capacity for Journal Watch Neurology.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Kummer, B., Parikh, N., Merkler, A., Kamel, H. Tags: Cerebrovascular Disease Health Services Research Source Type: research

Abstract 043: Health Insurance and the Risk of Incident Cardiovascular Disease in the Multi-Ethnic Study of Atherosclerosis Session Title: Poster Session I
Conclusions: The association of health insurance with CVD incidence varied by insurance group, and private insurance was associated with a lower risk of incident CVD. Further exploration of the features of health insurance coverage that impact CVD incidence may facilitate improvements in the primary prevention of CVD.
Source: Circulation: Cardiovascular Quality and Outcomes - March 31, 2017 Category: Cardiology Authors: Crim, M. T., Xie, J. X., Ko, Y.-A., Blumenthal, R. S., Blaha, M. J., Nasir, K., Budoff, M. J., Shaw, L. J. Tags: Session Title: Poster Session I Source Type: research

2017 Alzheimer's disease facts and figures
This article describes the public health impact of Alzheimer's disease (AD), including incidence and prevalence, mortality rates, costs of care, and the overall impact on caregivers and society. The Special Report examines how the use of biomarkers may influence the AD diagnostic process and estimates of prevalence and incidence of the disease. An estimated 5.5 million Americans have Alzheimer's dementia. By mid-century, the number of people living with Alzheimer's dementia in the United States is projected to grow to 13.8 million, fueled in large part by the aging baby boom generation. Today, someone in the country develo...
Source: Alzheimer's and Dementia: The Journal of the Alzheimer's Association - March 14, 2017 Category: Geriatrics Source Type: research

Prevalence of epilepsy/seizures as a comorbidity of neurologic disorders in nursing homes
Conclusions: The prevalence of epi/sz in the elderly nursing home population is >7-fold higher compared to community-dwelling elderly and is 7 to 30 times higher among those with certain comorbid neurologic conditions. Demographics and clinical characteristics had weaker associations with epi/sz prevalence.
Source: Neurology - February 19, 2017 Category: Neurology Authors: Birnbaum, A. K., Leppik, I. E., Svensden, K., Eberly, L. E. Tags: All Cerebrovascular disease/Stroke, All Cognitive Disorders/Dementia, Brain trauma, Prevalence studies, All Epilepsy/Seizures ARTICLE Source Type: research

Chronic Obstructive Pulmonary Disease Readmissions and Other Measures of Hospital Quality.
CONCLUSIONS: These findings suggest there may be common organizational factors that influence multiple disease-specific outcomes. As pay-for-performance programs focus attention on individual disease outcomes, hospitals may benefit from in-depth assessments of organizational factors affecting multiple aspects of hospital quality. PMID: 28145726 [PubMed - as supplied by publisher]
Source: American Journal of Respiratory and Critical Care Medicine - January 31, 2017 Category: Respiratory Medicine Authors: Rinne ST, Castaneda J, Lindenauer PK, Cleary PD, Paz HL, Gomez JL Tags: Am J Respir Crit Care Med Source Type: research

Differences in Use of High-quality and Low-quality Hospitals Among Working-age Individuals by Insurance Type
Background: Research suggests that individuals with Medicaid or no insurance receive fewer evidence-based treatments and have worse outcomes than those with private insurance for a broad range of conditions. These differences may be due to patients’ receiving care in hospitals of different quality. Research Design: We used the Healthcare Cost and Utilization Project State Inpatient Databases 2009–2010 data to identify patients aged 18–64 years with private insurance, Medicaid, or no insurance who were hospitalized with acute myocardial infarction, heart failure, pneumonia, stroke, or gastrointestinal hemorrhage. Mul...
Source: Medical Care - January 16, 2017 Category: Health Management Tags: Original Articles Source Type: research

Stroke Risk Reduction Outweighed Bleeding Risk Increase from Vitamin K Antagonists Treatment among Nonvalvular Atrial Fibrillation Patients with High Stroke risk and Low Bleeding Risk.
CONCLUSION: In NVAF patients at high risk for stroke and low risk for bleeding, our data confirm the effectiveness of anticoagulation for stroke prevention. The decrease in stroke risk of anticoagulation may outweigh the risk of major bleeding events, particularly among elderly patients. Potential risks of warfarin during initiation warrant attention, especially among patients who stop and start therapy repeatedly. PMID: 28008771 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - December 25, 2016 Category: Research Tags: Curr Med Res Opin Source Type: research

Insurance Type and Major Complications After Hysterectomy
Objectives: The aim of this study was to investigate the relationship between primary insurance type and major complications after hysterectomy. Methods: A retrospective analysis was performed on women with Medicaid, Medicare, and private insurance who underwent hysterectomy from January 1, 2012, to July 1, 2014, and were included in the Michigan Surgical Quality Collaborative. Major complications within 30 days of surgery included the following: deep/organ space surgical site infection, deep venous and pulmonary thromboembolism, myocardial infarction or stroke, pneumonia or sepsis, blood transfusion, readmission, and dea...
Source: Journal of Pelvic Medicine and Surgery - December 20, 2016 Category: Surgery Tags: Original Articles Source Type: research

Silk Road touts low stroke rate in 2 studies of Enroute TCAR system
Silk Road Medical yesterday released data from 2 studies of its Enroute transcarotid neuroprotection and stent system, including 1-year data from a pivotal trial of the device and an interim analysis of a post-approval study of the Enroute. Data from the studies was presented last month at the 44th annual Veith Symposium in New York. The Sunnyvale, Calif.-based company touts the Enroute system and stent as the 1st and only devices currently approved for transcarotid artery revascularization procedures by the FDA. Silk Road presented data from the Roadster 1 pivotal trial of the TCAR system, which examined the use of ...
Source: Mass Device - December 13, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Vascular Silk Road Medical Inc. Source Type: news

NSAIDs Prescription Prevalence after a Cardiovascular Event Related Hospitalization in Medicaid Beneficiaries from Puerto Rico.
CONCLUSION: Almost 20% of all beneficiaries who were hospitalized for a CV event received an NSAID during the study period, with 10% of patients receiving it during the immediate 90 days post-discharge. It represents a major challenge for our healthcare system, as it may reflect unawareness on the impact of proved evidence in clinical decision making. PMID: 27898167 [PubMed - in process]
Source: Puerto Rico Health Sciences Journal - December 1, 2016 Category: Global & Universal Tags: P R Health Sci J Source Type: research

Does Identification of Previously Undiagnosed Conditions Change Care ‐Seeking Behavior?
ConclusionsIn‐home assessment of cholesterol, blood pressure, and blood glucose can increase doctor visits for individuals with previously undiagnosed conditions. However, biomarker assessment may have more limited impact among individuals with low access to care.
Source: Health Services Research - November 30, 2016 Category: Health Management Authors: Rebecca M. Myerson, Lisandro D. Colantonio, Monika M. Safford, Elbert S. Huang Tags: Research Article Source Type: research

Prominent cardiologist calls for a halt to Watchman implants
A prominent cardiologist is calling for a stop to left atrial appendage closure procedures using Boston Scientific‘s (NYSE:BSX) Watchman device, claiming the procedures, which seek to reduce stroke in patients with nonvalvular atrial fibrillation, result in the opposite. Dr. John Mandrola argues that randomized, controlled trials of the Watchman, designed for LAA closure, showed the device failed to reduce ischemic stroke, despite being designed for just that purpose. “Yet we look away; or we let advocates distract us with complicated statistics,” Dr. Mandrola wrote in an article on Medscape. “I...
Source: Mass Device - November 10, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Cardiovascular Boston Scientific Source Type: news